HA Sustainable Infrastructure Capital vs National Health Investors
HASI and NHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HASI and NHI compare
HA Sustainable Infrastructure Capital is the larger company, worth 1.6 times as much as National Health Investors ($5.0B against $3.1B).
On earnings, National Health Investors is cheaper: it trades at 4.4× trailing earnings, against 38.8× for HA Sustainable Infrastructure Capital.
National Health Investors grew revenue faster over the last twelve months (28.2% versus 22.6% for HA Sustainable Infrastructure Capital).
National Health Investors keeps more of each dollar of sales as profit, with a net margin of 153% compared with 31.5% at HA Sustainable Infrastructure Capital.
Both pay dividends: HA Sustainable Infrastructure Capital yields 4.4% and National Health Investors 5.9%.
National Health Investors scores higher on the StockData Score (15 against 10 for HA Sustainable Infrastructure Capital), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HASI | NHI |
|---|---|---|
| Size and price | ||
| Market cap | $5.0B | $3.1B |
| Share price | $38.80 | $62.95 |
| Change, 1 year | 14.4% | −17.3% |
| Change, 5 years | −38.1% | 12.5% |
| Beta (5Y) | 1.31 | 0.34 |
| Employees | 178 | 32 |
| StockData Score | ||
| Total score | 10 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 4 | 5 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | 38.8× | 4.4× (better) |
| P/S | 10.5× | 6.8× (better) |
| P/B | – | 1.5× |
| EV/EBITDA | 9.6× | – |
| PEG | 0.88 | 0.16 (better) |
| Fair value | $32.75 | – |
| Margin of safety | −18.5% | – |
| Growth | ||
| Revenue growth (TTM) | 22.6% | 28.2% (better) |
| Revenue growth, 5Y average | 16.5% (better) | 2.5% |
| Net income growth (TTM) | −51.6% | 374% (better) |
| EPS growth (TTM) | −56.7% | 349% (better) |
| EPS growth, 5Y average | 5.1% (better) | −6.1% |
| Profitability | ||
| Net margin | 31.5% | 153% (better) |
| Return on equity | – | 39.1% |
| Financial health | ||
| Net debt / EBITDA | 0.65 | – |
| Altman Z-score | 0.44 | 3.24 (better) |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 4.4% | 5.9% (better) |
| Payout ratio | 149% | 25.5% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | −4.6% |
| Buyback yield | −0.99% (better) | −3.0% |
| Shareholder yield | 3.4% (better) | 2.9% |
| Ownership | ||
| Held by institutions | 103% | 77.7% |
| Held by insiders | 0.72% | 2.5% |
| Insider net buying, 12 months | −$5.3M | $167K (better) |
| Short interest, % of float | 11.6% | 4.6% |
Go deeper
- HASI stock overview
- HASI income statement
- HASI valuation and score
- NHI stock overview
- NHI income statement
- NHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.